Ischemic Stroke Clinical Trial
Official title:
Intermittent Fasting Following Acute Ischemic Stroke: Prospective, Randomized, Parallel Group, Controlled Trial
Despite numerous kinds of evidence on functional health and CNS protection of intermittent fasting after injuries were found in many brain-, and spinal cord-damaged animal models, there has yet to be any clinical study of intermittent fasting after acute ischemic cerebral infarction. The aim of this study is to evaluate the neurological, functional and clinical efficacy of intermittent fasting in patients after acute ischemic stroke.
Status | Recruiting |
Enrollment | 68 |
Est. completion date | January 31, 2021 |
Est. primary completion date | January 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years and older |
Eligibility |
Inclusion Criteria: - Patients who was diagnosed first ischemic stroke within preceeding 1 year through brain MRI/CT Exclusion Criteria: - Musculo-skeletal disease with limbs malformation or joint contracture - Weigh more than 135 kg or taller than 195 cm - Diabetes mellitus - unstable patient in neurology - Refusal of participation |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Ulsan University Hospital | Ulsan |
Lead Sponsor | Collaborator |
---|---|
Ulsan University Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change of Mini mental status exam | Mini mental status exam(minimum of 0 and maximum scores of 30); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Beck depression inventory | Beck depression inventory(minimum of 0 and maximum scores of 63); higher values and a worse outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Wecsler aphasia battery | Wecsler aphasia battery(minimum of 0 and maximum scores of 100); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Berg balance scale | Berg balance scale(minimum of 0 and maximum scores of 56); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Functional Ambulation Category | Functional Ambulation Category(minimum of 0 and maximum scores of 5); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Motricity Index | Motricity Index(minimum of 0 and maximum scores of 99); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of 10m walking test | 10m walking test | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Grasping force (kg) | Grasping force (kg) | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of 9-hole pegboard | 9-hole pegboard | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Jebsen Taylor test | Jebsen-Taylor Hand Function Test | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Nottingham sensory scale | Nottingham sensory scale(minimum of 0 and maximum scores of 20); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Arm motor Fugl-Mayer scale | Arm motor Fugl-Mayer scale; wrist & hand/proximal arm(minimum of 0 and maximum scores of 24 and of 34, respectively ); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Stroke impact scale | Hand motor, Stroke Impact Scale (minimum of 12 and maximum scores of 60); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Ashworth scale | Ashworth scale; elbow, wrist, knee & ankle(minimum of 0 and maximum scores of 4); higher values and a worse outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Knee joint kinesthesia | The smallest iso-kinetic angle from which the participants could detect any passive flexion or extension movement of their own knee, using Biodex; (minimum of 0 and maximum scores of 360 degree); higher values and a worse outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Behavioral inatention test | Behavioral inatention test(minimum of 0 and maximum scores of 146); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of Apraxia screen of Tulia | Apraxia screen of (minimum of 0 and maximum scores of 12); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset | |
Other | Change of motor evoked potential | Amplitude (uV) of motor evoked potential was recorded on abductor pollicis brevis and extentor digitorum brevis following trans-cranial magnetic stimulation for cortico-spinal excitability. | 1 day before the initiation of intervention, and 6 months after the stroke onset | |
Other | Change of Weight | Weight (Kg) | 1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention | |
Other | Change of Temperature | temperature (Celsius) | 1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention | |
Other | Change of Serum glucose level | Serum glucose level (mg/ml) | 1 day before the start of intervention and 1 weeks and 2 weeks after the start of intervention | |
Other | Change of Hypoglycemia-related severity | Assessment of hypoglycemic symptoms using Likert scale (minimum of 0 and maximum scores of 10); higher values and a worse outcome. | every day following the start of intervention until 2 weeks of intervention | |
Primary | Change of Surface electromyography | root mean square and root peak square of compound motor action potential | 1 day before the initiation of intervention, and 6 months after the stroke onset | |
Secondary | Change of Korean-modified Barthel index | Korean version-Modified Barthel Index (minimum of 0 and maximum scores of 100); higher values and a better outcome. | 1 day before the initiation of intervention and 3rd week after start of intervention, 3 months and 6 months after the stroke onset |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |